Thorne HealthTech (THRN) IPO Opens Lower

Today's IPO for Thorne HealthTech (NASDAQ: THRN) opened for trading at $8.50 after pricing 7,000,000 shares of its common stock at a price to the public of $10.00 per share.

BofA Securities, Cowen and Evercore ISI are acting as lead book-running managers for the proposed offering. RBC Capital Markets is acting as an additional book-running manager.

Thorne HealthTech is a leader in developing innovative solutions for a personalized approach to health and wellbeing. Thorne HealthTech is a science-driven wellness company that is utilizing testing and data to create improved product efficacy and deliver personalized solutions to consumers, health professionals, and corporations. Thorne HealthTech's unique, vertically integrated brands, Thorne and Onegevity, provide insights and personalized data, products, and services that help individuals take a proactive and actionable approach to improve and maintain their health over a lifetime.

You May Also Be Interested In

• Market Technology Acquisition Corp closes $205M IPO on Nasdaq
• Scribe Therapeutics prices IPO at $15 per share on Nasdaq
• Scribe Therapeutics raises $155.51M in IPO on Nasdaq